Micafungin Injection, Powder, Lyophilized, For Solution
Product Images NDC 67184-0589

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Micafungin (NDC 67184-0589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qilu Pharmaceutical Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Formula Of Micafungin Sodium (Image 01)

Chemical structure of micafungin, depicting its complex molecular composition with multiple ring systems and functional groups characteristic of the antifungal agent.*

FDA Label Image

Container Label For Strength 50 mg/vial (Image 02)

Label for MICAFUNGIN 50 mg per vial, Micafungin for Injection, USP, a lyophilized powder for intravenous infusion. The label indicates each mL of reconstituted solution contains 10 mg micafungin. Manufactured and marketed by Qilu Pharmaceutical (Hainan) Co., Ltd in China. Storage instructions and product identifiers including NDC 67184-0589-1 are shown.*

FDA Label Image

Container Label For Strength 100 mg/vial (Image 03)

Label for Micafungin for Injection, USP 100 mg/vial powder for solution, manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd. It details reconstitution to 20 mg/mL micafungin for intravenous infusion, with storage instructions and sterility information. The label includes barcode and placeholder for lot, expiration, and GTIN data.*

FDA Label Image

Carton Labeling Of Single Vial For Strength 50 mg/vial (Image 04)

Micafungin for Injection, USP 50 mg/vial powder for solution label from Qilu Pharmaceutical Co., Ltd. It is a single-dose vial for intravenous infusion only. The label specifies nonpyrogenic, preservative-free sterile powder containing micafungin sodium equivalent to 50 mg micafungin per vial. Storage instructions and usage notes, including dilution requirements and precautions, are included. The product is manufactured and marketed in China.*

FDA Label Image

Carton Labeling Of Single Vial For Strength 100 mg/vial (Image 05)

The packaging label for MICAFUNGIN for Injection, USP, 100 mg/vial, lyophilized powder for intravenous solution. The label indicates it is a single-dose vial for intravenous infusion only, manufactured and marketed by Qilu Pharmaceutical Co., Ltd in China. It includes storage instructions, active ingredient details, and dispensing directions, with a barcode and lot information panel.*

FDA Label Image

Carton Labeling Of Ten Vials For Strength 50 mg/vial (Image 06)

Packaging label for Micafungin for Injection, USP, 50 mg/vial, lyophilized powder for solution, intended for intravenous infusion. The label highlights a 50 mg strength per vial, and the package contains 10 vials. It indicates the product is sterile, nonpyrogenic, for single-dose use, and manufactured by Qilu Pharmaceutical Co., Ltd in China.*

FDA Label Image

Carton Labeling Of Ten Vials For Strength 100 mg/vial (Image 07)

Packaging label for MICAFUNGIN 100 mg/vial injection, powder, lyophilized, for solution, USP. The label indicates it is a sterile, nonpyrogenic powder for intravenous infusion, manufactured and marketed by Qilu Pharmaceutical Co., Ltd. The vial strength is 100 mg with 10 vials per package. Additional details include storage conditions, dosing instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.